- According to estimates from 5 analysts, Collegium Pharmaceutical, Inc. stock's average price target has fallen from $53.6 to $51.2, with forecasts ranging from $43 to $60 per share
- Based on the Aug. 5 closing price, the updated target implies approximately 43% potential upside
- Consensus rating remains at “Buy” across 5 covering analysts, with 4 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Collegium Pharmaceutical, Inc. on the , and track all previous and future analyst recommendations for Collegium Pharmaceutical, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.